Medication, clinical practice recommendations, and care paradigms for obesity control are emerging fast.
The Boston Course in Obesity Medicine will offer a 2023 professional education program to keep physicians, policymakers, researchers, and others up to date on obesity science and clinical care.
essential points for The Boston Course in Obesity Medicine:
- Major phase 3 tripeptide obesity trial SURMOUNT-1 is discussed. Trial participants lost up to 22% weight.
- The STEP TEENS study found that semaglutide 2.4 mg weekly helped adolescent obesity. The study demonstrated a great 17% weight loss.
- New ICER report on anti-obesity medicine efficacy and cost.
- Recent studies demonstrate how the body resists calorie-reduction-only weight loss. These studies also suggest that GLP-1 receptor agonists overcome this resistance.
- Recent research shows processed food hazards.
- New research shows the merits and cons of timed feeding and intermittent fasting.
- Weight bias, stigma, and discrimination have significant health and psychosocial implications, according to a recent study. Canadian obesity evaluation and management clinical practice guidelines were published recently.
- Summary of one-year phase 2 resmethrin trial, indicating NASH resolution and liver fibrosis improvement.
- New clinical guidelines for NAFLD and NASH evaluation and management are available.
- A landmark study demonstrated that bariatric surgery reduced cancer incidence and mortality over time.
- Metabolism and bariatric surgery enhance renal disease signs for the first time.
- New research has improved metabolic and bariatric surgery safety and advantages.
- New clinical guidelines for metabolic and bariatric surgery selection and use are available.
- Exciting new research suggests that endoscopic procedures are better for obesity, diabetes, and NAFLD.
- Exciting new research shows that combining obesity therapies has significant benefits in The Boston Course in Obesity Medicine.
- Enhancing obesity care organization and distribution creatively
- Innovative obesity care plans are underway for all patients.
- To improve care, obesity-focused firms have emerged.
- Payers and legislators realize obesity treatment’s clinical and economic benefits. Improving obesity treatment reimbursement and decreasing medical implications begins with this recognition.
See Also: Brain Injury Medicine Board Review (Publisher PDF)
Reviews
There are no reviews yet.